172@29@17@144!~!172@29@0@53!~!|news|business|earnings|strides-pharma-standalone-december-2019-net-sales-at-rs-364-47-crore-down-12-11-y-o-y-4880131.html?utm_source=MC_OpeninApp!~!|controller|infinite_scroll_article.php
Moneycontrol
Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ₹15,000/-
Last Updated : Jan 30, 2020 02:39 PM IST | Source: Moneycontrol.com

Strides Pharma Standalone December 2019 Net Sales at Rs 364.47 crore, down 12.11% Y-o-Y

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Strides Pharma Science are:

Net Sales at Rs 364.47 crore in December 2019 down 12.11% from Rs. 414.68 crore in December 2018.

Close

Quarterly Net Profit at Rs. 13.65 crore in December 2019 down 10.84% from Rs. 15.31 crore in December 2018.

EBITDA stands at Rs. 54.47 crore in December 2019 down 0.82% from Rs. 54.92 crore in December 2018.

Strides Pharma EPS has decreased to Rs. 1.52 in December 2019 from Rs. 1.71 in December 2018.

Strides Pharma shares closed at 446.90 on January 29, 2020 (NSE) and has given 26.69% returns over the last 6 months and -8.91% over the last 12 months.

Strides Pharma Science
Standalone Quarterly Resultsin Rs. Cr.
Dec'19Sep'19Dec'18
Net Sales/Income from operations364.47425.41414.68
Other Operating Income------
Total Income From Operations364.47425.41414.68
EXPENDITURE
Consumption of Raw Materials208.60161.98229.53
Purchase of Traded Goods9.395.664.88
Increase/Decrease in Stocks-20.1757.335.76
Power & Fuel------
Employees Cost50.7756.0552.94
Depreciation22.5514.8820.23
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses79.0380.8088.72
P/L Before Other Inc. , Int., Excpt. Items & Tax14.3048.7112.62
Other Income17.6232.2022.07
P/L Before Int., Excpt. Items & Tax31.9280.9134.69
Interest16.3922.6914.94
P/L Before Exceptional Items & Tax15.5358.2219.75
Exceptional Items-----1.95
P/L Before Tax15.5358.2217.80
Tax1.8811.222.49
P/L After Tax from Ordinary Activities13.6547.0015.31
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period13.6547.0015.31
Equity Share Capital89.5589.5589.55
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS1.525.251.71
Diluted EPS1.525.251.71
EPS After Extra Ordinary
Basic EPS1.525.251.71
Diluted EPS1.525.251.71
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited
 
First Published on Jan 30, 2020 02:18 pm
Sections